Suppr超能文献

大鼠血清酸性胆固醇酯水解酶抑制剂的特性

Properties of an acid cholesteryl ester hydrolase inhibitor from rat serum.

作者信息

Tanaka M, Iio T, Tabata T

机构信息

Showa College of Pharmaceutical Sciences, Tokyo, Japan.

出版信息

Lipids. 1990 Dec;25(12):775-8. doi: 10.1007/BF02535896.

Abstract

The inhibitory effect of a protein isolated from rat serum on lysosomal acid cholesteryl ester hydrolase (acid CEH; EC.3.1.1.13) activity was studied. An inhibitor was purified from rat serum following ultracentrifugation and heat treatment using column chromatography on Sephacryl S-200 and ultrafiltration. The purified inhibitor appeared as a single protein band in sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. The molecular weight of the inhibitor was 28,000 Daltons as judged by gel filtration on Sephacryl S-200 and SDS-polyacrylamide gel electrophoresis. The purified inhibitor was shown to be apolipoprotein A-I (apo A-I), the major apolipoprotein of high-density lipoprotein (HDL), using immunoprecipitation with rat anti-apo A-I immunoglobulin (Ig)G. Inhibition of acid CEH activity by apo A-I was dependent on the concentration of apo A-I. The values of Vmax obtained were similar with or without apo A-I. Apo A-I of various other mammalian species, including human, bovine and rabbit, also inhibited acid CEH activity. Other apolipoproteins, such as apo A-II and apo B, also showed inhibiting activity. On the other hand, apo A-I had no effect on the activity of other enzymes found in lysosomes, such as cathepsin D, beta-glucuronidase and acid phosphatase. The results suggest that apolipoproteins may play a role in the regulation of hydrolysis of cholesteryl esters in lipoproteins, that have been transferred to the liver, and that the inhibition of acid CEH activity by apo A-I may be a characteristic of the lipid-binding protein or be due to changes of the lipid/water interface.

摘要

研究了从大鼠血清中分离出的一种蛋白质对溶酶体酸性胆固醇酯水解酶(酸性CEH;EC.3.1.1.13)活性的抑制作用。通过在Sephacryl S - 200上进行柱色谱和超滤,从经超速离心和热处理的大鼠血清中纯化出一种抑制剂。纯化后的抑制剂在十二烷基硫酸钠(SDS)-聚丙烯酰胺凝胶电泳中呈现为单一蛋白条带。通过Sephacryl S - 200凝胶过滤和SDS -聚丙烯酰胺凝胶电泳判断,该抑制剂的分子量为28,000道尔顿。使用大鼠抗载脂蛋白A - I免疫球蛋白(Ig)G进行免疫沉淀,结果表明纯化后的抑制剂为载脂蛋白A - I(apo A - I),即高密度脂蛋白(HDL)的主要载脂蛋白。apo A - I对酸性CEH活性的抑制作用取决于apo A - I的浓度。无论有无apo A - I,所获得的Vmax值相似。包括人类、牛和兔在内的各种其他哺乳动物物种的apo A - I也抑制酸性CEH活性。其他载脂蛋白,如apo A - II和apo B,也表现出抑制活性。另一方面,apo A - I对溶酶体中发现的其他酶的活性没有影响,如组织蛋白酶D、β - 葡萄糖醛酸酶和酸性磷酸酶。结果表明,载脂蛋白可能在调节已转运至肝脏的脂蛋白中胆固醇酯的水解中发挥作用,并且apo A - I对酸性CEH活性的抑制可能是脂质结合蛋白的特性或由于脂质/水界面的变化所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验